COMPARATIVE MEDICINE SHARED RESOURCE (CMSR) The Comparative Medicine Shared Resource (CMSR), located at the Fred Hutch (FH), provides high quality support for preclinical research performed by Consortium investigators. It achieves this through specialized support structures, technology, and personnel expertise. CMSR maintains an AAALAC-accredited, USDA- registered, and PHS-assured facility. CMSR is staffed by three clinical veterinarians with expertise in laboratory animal medicine, animal-use regulations, and facility management and husbandry. An additional 45 personnel provide daily care and treatment to five species of animals currently housed at FH ? mice, rats, dogs, fish, and guinea pigs ? and deliver exceptional husbandry to maintain microbiologic and environmental control of animal colonies. This care encompasses the needs of many specialized animal models of cancer and cancer-related disease states such as transplanted or induced liquid and solid tumors, cancer-related pathogens, graft- versus-host disease, and conditions and treatments related to radiation therapy. The small animal facility is a centralized barrier facility with special areas to accommodate radioactive agents and infectious agents. CMSR specialty services include patient-derived-xenograft (PDX) models and preclinical imaging support in collaboration with the Translational BioImaging Core Shared Resource (TBICSR). A full time veterinary comparative pathologist is available for consultation and collaboration with researchers. Equipment support for CMSR includes individually ventilated micro-isolator rodent cages, a full service rodent cage wash and autoclaves, and numerous surgical-ready procedure rooms for rodent users. Canine support includes specialized housing for Severe Combined Immune Deficiency (SCID) and Pyruvate Kinase (PK) deficient animals, a comprehensive surgical suite and procedure area, and a Linear Accelerator dedicated to preclinical research. CMSR supplies an invaluable, centralized resource to support high quality preclinical studies. Historically, animal models contributed to Nobel Prize winning research in bone marrow transplantation and hematopoietic cancers. The continued expansion of scope and volume of animal-related work now includes solid tumor and cancer-related pathogen research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-46
Application #
10125957
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-01
Project End
2024-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
46
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Holly, Mayumi K; Smith, Jason G (2018) Adenovirus infection of human enteroids reveals interferon sensitivity and preferential infection of goblet cells. J Virol :
Cheng, Heather H (2018) The resounding effect of DNA repair deficiency in prostate cancer. Urol Oncol 36:385-388
Poudel, Kumud R; Roh-Johnson, Minna; Su, Allen et al. (2018) Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis. Dev Cell 45:738-752.e6
Eaton, Keith D; Romine, Perrin E; Goodman, Gary E et al. (2018) Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility. J Thorac Oncol 13:649-659
Bar, Merav; Flowers, Mary E D; Storer, Barry E et al. (2018) Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial. Biol Blood Marrow Transplant 24:308-313
Gauthier, Jordan; Turtle, Cameron J (2018) Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy. Curr Res Transl Med 66:50-52
Graves, Scott S; Parker, Maura H; Stone, Diane et al. (2018) Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:50-54
Méndez, Eduardo; Rodriguez, Cristina P; Kao, Michael C et al. (2018) A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 24:2740-2748
Amundsen, Susan K; Smith, Gerald R (2018) The RecB helicase-nuclease tether mediates Chi hotspot control of RecBCD enzyme. Nucleic Acids Res :
Montgomery, Elizabeth T; Noguchi, Lisa M; Dai, James Y et al. (2018) Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States. AIDS Behav 22:402-411

Showing the most recent 10 out of 1267 publications